Immunicum AB Announces Update on Corporate and Clinical Development Strategy

BioTech 365

Press Release 30 September 2020 Immunicum AB Announces Update on Corporate and Clinical Development Strategy Immunicum AB (publ: IMMU.ST) announced today an update on the Company’s corporate and clinical development strategy. The strategy will be presented by members of the … Continue reading → GlobeNewswire

ESCAPE Bio Snags $73 Million to Advance Neurodegenerative Clinical Development Programs

BioSpace

Clinical-stage biopharmaceutical firm ESCAPE Bio has snagged a $73 million crossover financing deal, led by Wellington Management Company, which will help advance the company’s two clinical development programs of precision neurology medicines for patients with genetic neurodegeneration

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Novartis Provides Update on AVXS-101 Intrathecal Clinical Development Program

The Pharma Data

Trial design and other details are being evaluated and a comprehensive update on the overall Novartis SMA clinical development program will be provided at a future time following further discussions with health authorities.

Novartis Provides Update on AVXS-101 Intrathecal Clinical Development Program

BioTech 365

Novartis Gene Therapies to initiate new pivotal confirmatory study to evaluate use of AVXS-101 intrathecal (IT) formulation in older patients with SMA to further support registration Basel, September 23, 2020 – Novartis Gene Therapies recently received feedback from the US … Continue reading → GlobeNewswire

Confo Therapeutics Announces Selection of First Product Candidate and Initiation of Pre-Clinical Development

BioTech 365

GHENT, Belgium–(BUSINESS WIRE)–Confo Therapeutics today announced the selection of its first preclinical drug candidate, CFTX-1554, a compound designed to address peripheral neuropathic pain with the potential to address additional pain indications.

WHO: remdesivir shows little effect on COVID-19

Outsourcing Pharma

Clinical DevelopmentThe agencyâs Solidarity Therapeutics Trial examined a range of drugs repurposed for COVID-19 treatment, finding nearly no effect on patient mortality.

Trials 107

ViiV Healthcare Announces Analysis Showing no Antiretroviral Therapy Interruptions Due to COVID-19 Across its Clinical Development Programme for Investigational, Long-Acting Cabotegravir and Rilpivirine

The Pharma Data

and Shionogi Limited as shareholders, today announced the positive findings of a pooled analysis of COVID-19-related impacts across the investigational long-acting cabotegravir and rilpivirine clinical development programme. Clinical Trails

Anova Announces Formation of Scientific Advisory Board to Advance Development of Its Technology Platform Transforming Clinical Development

BioTech 365

LONDON & CHICAGO–(BUSINESS WIRE)–#advisoryboard–Anova Enterprises, Inc.

Clinical trials have ‘much work to do’ in boosting diversity

Outsourcing Pharma

Clinical DevelopmentA veteran with more than 20 years of experience talks about the vitality of recruiting an inclusive patient population, and the perils of falling short.

TPG Forms Ellodi Pharmaceuticals to Continue Clinical Development of APT-1011 for Treatment of Eosinophilic Esophagitis

BioTech 365

TPG Capital establishes new entity to continue the development of select clinical assets spun-out of Adare Pharmaceuticals Announcement follows TPG Capital’s sale of Adare Pharmaceuticals’ specialty CDMO pharmaceutical technology and microbiome businesses SAN FRANCISCO & FORT WORTH, Texas–(BUSINESS WIRE)–TPG Capital, … Continue reading → Business Wire

Sales 40

FSD Pharma Phase II COVID-19 trial gets go-ahead

Outsourcing Pharma

Clinical DevelopmentThe companyâs Phase II trial of ultramicronized PEA has received FDA approval and expects to begin dosing patientparticipants as early as next month.

COVID-19 response makes NZ an appealing trial destination

Outsourcing Pharma

Clinical DevelopmentA leader from a New Zealand-based CRO talks about the countryâs handling of the pandemic, and how their low rates are making sponsors take notice.

Potential HIV cure Phase I trial gets FDA green light

Outsourcing Pharma

Clinical DevelopmentAmerican Gene Technologies has received the agencyâs approval to launch the first human trial for its lead HIV program, starting in Baltimore and DC.

Gene 114

Study looks at COVID-era mobile health applications

Outsourcing Pharma

Clinical DevelopmentLed by the Spaulding Rehabilitation Hospital, a study by a 60-person task force shows ways mobile health tech can help mitigate the pandemicâs effects.

Exelixis and Aurigene Announce That Promising Preclinical Data to Be Presented at the ENA Symposium Support the Clinical Development of a Novel CDK7 Inhibitor

BioTech 365

– Detailed characterization of an oral inhibitor of CDK7 demonstrates potent activity against multiple hematologic and solid tumor cell lines, as monotherapy and in combination with chemotherapies – ALAMEDA, Calif.–(BUSINESS –(BUSINESS WIRE)–Exelixis, Inc.

PRA: get ready for the RACE Act

Outsourcing Pharma

Clinical DevelopmentExperts from the CRO offers insight on preparing for the changes to the pediatric oncology research requirements, which take effect next week.

Parexel: improving trial diversity can elevate outcomes

Outsourcing Pharma

A representative from the pharma services firm discusses how increasing diversity of clinical trial populations can improve research effectiveness. Clinical Development

First COVID-19 patient treated in Noxopharm study

Outsourcing Pharma

The clinical-stage drug development company has kicked off testing the experimental anticancer drug Veyonda on severe patients in a Phase I trial. Clinical Development

Drugs 61

FHI Clinical, Oracle partner on cloud-based trial tech

Outsourcing Pharma

The CRO and life-sciences tech firm collaborated on a solution capable of meeting challenges tied to starting and conducting global clinical trials. Clinical Development

First patient dosed in long-term Alzheimer’s trial

Outsourcing Pharma

Clinical DevelopmentNeurotrope has kicked off its ongoing Phase II study of Bryostatin-1 for treatment of Alzheimerâs disease, with the help of a $2.7m NIH grant.

Notable, Washington University join on oncology study

Outsourcing Pharma

Clinical DevelopmentThe precision study at the center of the partnership is geared toward identifying novel synergies across a broad variety of anticancer therapies.

BARDA enlists Current Health in COVID-19 monitoring

Outsourcing Pharma

Clinical DevelopmentThe collaboration will target signs of early deterioration in patients, and predict infection severity to let caregivers know when to escalate care.

Investors bet on decentralized trial technology

Outsourcing Pharma

Companies like Biofourmis, THREAD and other virtual tech specialists have seen infusions of funds from investors bullish on decentralized clinical trials. Clinical Development

NIH kicks off COVID-19 immune modulator trial

Outsourcing Pharma

The US agency has launched a large clinical trial to examine the viability of using immune modulators to treat patients hospitalized with COVID-19. Clinical Development

Cynata Therapeutics kicks off COVID-19 trial enrollment

Outsourcing Pharma

The clinical-stage biotech firm is investigating early efficacy of its Cymerus mesenchymal stem cells for treatment of severe COVID-19 patients. Clinical Development

Illingworth: mobile nursing can reduce trial patient burden

Outsourcing Pharma

A leader from home-based clinical services firm Illingworth Research Group talks about the evolution of mobile nursing and how it can keep trials going. Clinical Development

Clinical technology firm takes a human approach to trials

Outsourcing Pharma

blends behavioral science, decision economics and technology to better integrate the patient voice into clinical research. Clinical DevelopmentStudy solutions provider H?

Clinical trial volume, variety drive data solutions

Outsourcing Pharma

eClinical, a provider of clinical data service solutions, has seen an increase in interest in clinical data platform and other digital products. Clinical Development

Daxor research battles military injuries

Outsourcing Pharma

The company is delving into clinical research partnerships geared toward saving the lives of soldiers, eventually translating findings to civilian care. Clinical Development

RedHill’s Phase II/III COVID-19 research gets green light

BioPharma Reporter

Clinical DevelopmentThe companyâs studies exploring the use of opaganib in severe COVID-19 patients have been approved in Brazil and other countries around the globe.

Marken doubles capacity of Frankfurt cold-chain facility

Outsourcing Pharma

Clinical DevelopmentThe company has expanded the footprint of the location to accommodate an anticipated increase in the need for COVID-19 vaccine and storage needs.

Drug discovery platform aims to accelerate rare-disease therapies

Outsourcing Pharma

An online patient community specializing in rare diseases has launched Xperiome, a knowledge platform aimed at speeding development of treatments. Clinical Development

PRA partners on acute leukemia clinical trial

Outsourcing Pharma

The CRO will work with the Leukemia and Lymphoma Society on a global master clinical trial to explore treatments for pediatric acute leukemia. Clinical Development

hyperCORE names new CEO

Outsourcing Pharma

The clinical research site network has tapped 22-year industry veteran Karri Venn, president of research with LMC Manna, to lead the organization. Clinical Development

Berg fuels study of African-American COVID-19 patients

Outsourcing Pharma

Clinical DevelopmentResults from the research indicate use of ACE in inhibitors and ARBs could prove useful in treating COVID-19 patients of African-American descent.

Generex Signs Binding Licensing & Research Agreement with Bintai Kinden to Advance the Clinical Development & Commercialization of Ii-Key-SARS-CoV-2 Coronavirus Vaccine for Malaysia

BioTech 365

million 100% funding for development, manufacturing and commercial registration of Ii-Key- … Continue reading → GlobeNewswireBintai Kinden Corporation Berhad (www.bintai.com.my) is an investment holding company headquartered in Malaysia with operations throughout South-East Asia, China, and the Arabian Gulf Region Upfront licensing fee of $2.5

AstraZeneca unveils Phase III kidney treatment results

BioPharma Reporter

Clinical DevelopmentIn a Phase III trial, Farxiga reportedly showed reduction in the risk of kidney failure, and cardiovascular (CV) or renal death, in CKD patients.

Reify Health raises $30m for clinical trial tech

Outsourcing Pharma

The cloud-based study technology firm has secured Series B funding to help develop and promote products like its clinical trial platform, StudyTeam. Clinical Development

SciBite introduces insight-building AI software

Outsourcing Pharma

Clinical DevelopmentThe AI platform combines machine-learning models and advanced semantic technologies to help life-science users gain insights from their data.

Current Health: RPM can help clear COVID-19 challenges

Outsourcing Pharma

The health solutions firm is looking to remote patient monitoring to overcome significant clinical trial obstacles created by the ongoing pandemic. Clinical Development